ロード中...
Towards a novel influenza vaccine: engineering of hemagglutinin on a platform of adenovirus dodecahedron
BACKGROUND: The production process for the current influenza vaccine takes about 6 months and its antigenic composition must be modified annually. In the attempt towards developing influenza vaccine production that would be faster, safer and cheaper we engineered an influenza vaccine in which multip...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3688493/ https://ncbi.nlm.nih.gov/pubmed/23767961 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6750-13-50 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|